Lihua Wu

Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial

M. Ducreux, G. Abou-Alfa, W. Fang, 2022, Liver Cancer.

Establishment and verification of a nomogram to predict tumor-specific mortality risk in triple-negative breast cancer: a competing risk model based on the SEER cohort study

Yun Shi, Zhi Li, Long Duo, 2022, Gland surgery.

Lymphoepithelial carcinoma of the head and neck: a SEER analysis of prognostic factors for survival

Hui Deng, Mengxian Zhang, Wenhui Yang, 2023, The Journal of international medical research.

Efficacy of combination of venetoclax with azacitidine or chemotherapy in refractory/relapse acute leukemias of ambiguous lineage, not otherwise specified

Yan Li, Jianxiang Wang, Y. Mi, 2021, Experimental Hematology & Oncology.

Physical, language, neurodevelopment and phenotype-genotype correlation of Chinese patients with Mowat-Wilson syndrome

Bo Zhou, Lung-Chuang Wang, Lu Han, 2022, Frontiers in Genetics.

Tyrosine kinase inhibitors combined with venetoclax and azacytidine as an effective therapy for de novo lymphoid blast phase-chronic myeloid leukemia.

Junfan Li, Yali Zheng, Qingguo Liu, 2023, Leukemia research.